THE EFFECTS OF CITICOLINE AND LAMOTRIGINE ALONE AND IN COMBINATION FOLLOWING PERMANENT MIDDLE CEREBRAL ARTERY OCCLUSION IN RATS

References

• Alvarez, X. A., Laredo, M., Corzo, D., Fernández-Novoa, L., Mouzo, R., & Perea, J. E., et al. (1997). Citicoline improves memory performance in elderly subjects. Methods and Findings in Expeirmental and Clinical Pharmacology, 19, 201–210.
   PubMed Web of Science ®Google Scholar
• Aronowski, J., Strong, R., & Grotta, J. C. (1996). Citicoline for treatment of experimental focal ischemia: Histological and behavioral outcome. Neurological Research, 18, 570–574.
   PubMed Web of Science ®Google Scholar
• Astrup, J., Siesjo, B. K., & Symon, L. (1981). Threshold in cerebral ischemia: The is- chemic penumbra. Stroke, 12, 725.
   Web of Science ®Google Scholar
• Bacher, A., & Zomow, M. H. (1997). Lamotrigine inhibits extracellular glutamate ac- cumulation during transient global cerebral ischemia in rabbits. Anesthesiology, 86, 459–463.
   PubMed Web of Science ®Google Scholar
• Balkan, S., Özben, T., Balkan, E., Oguz, N., Serteser, M., & Gümüs¸lü, S. (1997). Effects of lamotrigine on brain nitrite and cGMP levels during focal cerebral ischemia in rats. Acta Neurologica Scandinavica, 95, 140–146.
   PubMed Web of Science ®Google Scholar
• Bazan, N. G. (1970). Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochimica et Biophysica Acta, 218, 1–10.
   PubMed Web of Science ®Google Scholar
• Calabresi, P., Centonze, D., Marfia, G. A., Pisani, A., & Bernardi, G. (1999). An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons. British Journal of Pharmacology, 126, 689–696.
   PubMed Web of Science ®Google Scholar
• Calabresi, P., Picconi, B., Saulle, E., Centonze, D., Hainsworth, A. H., & Bernardi, G. (2000). Is pharmacological neuroprotection dependent on reduced glutamate release? Stroke, 31, 766–773.
   PubMed Web of Science ®Google Scholar
• Clark, W., Gunion-Rinker, L., Lessov, N., & Hazel, K. (1998). Citicoline treatment for experimental intracerebral hemorrhage in mice. Stroke, 29, 2136–2140.
   PubMed Web of Science ®Google Scholar
• Clarke, W. M., Warach, S. J., Pettignew, L.C., Gammans, R. E., & Sabounjian, L. A. (1997). A randomized dose-response trial of citicoline in acute ischemic stroke pa- tients. Citicoline Stroke Study Group. Neurology, 49, 671–678.
   PubMed Web of Science ®Google Scholar
• Clarke, W. M., Williams, B. J., Selzer, K. A., Zweifler, R. M., Sabounjian, L. A., & Gammans,R. E. (1999). Citicoline Stroke Study Group: A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke, 30, 2592–2597.
   PubMed Web of Science ®Google Scholar
• Crumrine, R. C., Bergstrand, K., Cooper, A. T., Faison, W. L., & Cooper, B. R. (1997). Lamotrigine protects hippocampal CA1 neurons from ischemic damage after cardiac arrest. Stroke, 28, 2230–2236.
   PubMed Web of Science ®Google Scholar
• De Medio, G. E., Brunett, M., Dorman, R. V., Droz, B., Horrocks, L. A., & Porcellati, G. (1983). Phospholipid metabolism during central and peripheral damage and recovery in nervous tissue. Original article series. Birth Defects, 19, 175–187.
   PubMedGoogle Scholar
• Dorman, R. V., Dabrowiecki, Z., De Medio, G. E., Trovarelli, G., Porcellati, G., & Horroks, L. A. (1980). Control of lipid metabolism in ischemic brain CDP amines. In L. A. Horroks, G. B. Ansell, & G. Porcellati (Ed.), Phospholipids in the nervous system. Vol I: Metabolism (pp. 123–135). New York: Raven Press.
   Google Scholar
• Dyker, A. G., & Lees, K. R. (1998). Duration of neuroprotective treatment for ischemic stroke. Stroke, 29, 535–542.
   PubMed Web of Science ®Google Scholar
• Finkelstein, S. P., Fisher, M., Furlan, A. J., Goldstein, L. B., Gorelick, P. B., & Kaste, M., et al. (1999). Stroke therapy academic industry roundtable. Recommendations for stan- dards regarding preclinical neuroprotective and restorative drug development. Stroke, 30, 2752–2758.
   PubMed Web of Science ®Google Scholar
• Fisher, M., Meadows, M., Do, T., Weise, J., Trubetskoy, V., & Charette, M., et al. (1995). Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats. Journal of Cerebral Blood Flow and Metabolism, 15, 953–959.
   PubMed Web of Science ®Google Scholar
• Gilland, E., Puka-Sundvall, M., Andine, P., Bona, E., & Hagberg, H. (1994). Hypoxic- ischemic injury in the neonatal rat brain: Effects of pre- and post-treatment with the glutamate release inhibitor BW1003C87. Brain Research Development, 83, 79–84.
   PubMedGoogle Scholar
• Hayaishi, O., Ozawa, K., Araki, C., Ishii, S., & Kondo, Y. (1961). Biochemistry of brain injury and brain edema. Japanese Journal of Medical Progress, 48, 519–539.
   Google Scholar
• Kakihana, M., Fukuda, N., Suno, M., & Nagaoka, A. (1988). Effects of CDP-choline on neurological deficits and cerebral glucose metabolism in a rat model of cerebral ischemia. Stroke, 19, 217–222.
   PubMed Web of Science ®Google Scholar
• Koizumi, J., Yoshida, Y., Nakazawa, T., & Ooneda, G. (1986). Experimental studies of ischemic brain edema: 1. A new experimental model of cerebral embolism in rats in re- circulation can be introduced in the ischemic area. Japanese Journal of Stroke, 8, 1–8.
   Google Scholar
• Kuwashima, J., Fujitani, B., Nakamura, K., Kadokawa, T., Yoshida, K., & Shimizu, M. (1976). Biochemical changes in unilateral brain injury in the rat: A possible role of fatty acid accumulation. Brain Research, 110, 547–557.
   PubMed Web of Science ®Google Scholar
• Leach, M. J., Baxter, M. G., & Critchley M. A. (1991). Neurochemical and behavioral aspects of lamotrigine. Epilepsia, 32(Suppl 2), S4–S8.
   Web of Science ®Google Scholar
• Leach, M. J., Marden, C. M., & Miller, A. A. (1986). Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II Neurochemical studies on the mechanism of action. Epilepsia, 27, 490–497.
   PubMed Web of Science ®Google Scholar
• Lyden, P. D., & Lonzo, L. (1994). Combination therapy protects ischemic brain in rats; a glutamate antagonist plus an γ-aminobutyric acid agonist. Stroke, 25, 189–196.
   PubMed Web of Science ®Google Scholar
• Majeswska, M. D., Strosznajder, J., & Lazarewicz, J. (1978). Effect of ischemic anoxia and barbiturate anesthesia on free radical oxidation of mitochondrial phospholipids. Brain Research, 158, 423–434.
   PubMed Web of Science ®Google Scholar
• Minematsu, K., & Fisher, M. (1993). MK-801 reduces extensive infarction after suture middle cerebral artery occlusion in rats. Cerebrovascular Disease, 3, 99–104.
   Web of Science ®Google Scholar
• Minematsu, K., Li, L., Fisher, M., Sotak, C. H., Davis, M. A., & Fiandaca, M. S. (1992). Diffusion weighted magnetic resonance imaging: Rapid and quantitative detection of focal brain ischemia. Neurology, 42, 235–240.
   PubMed Web of Science ®Google Scholar
• Mykita, S., Golly, F., Dreyfus, H., Freysz, L., & Massarelli, R. (1986). Effects of CDP- choline on hypocampic neurons in culture. Journal of Neurochemistry, 47, 223–2231.
   PubMed Web of Science ®Google Scholar
• Önal, M. Z., & Fisher, M. (1997). Acute ischemic stroke therapy: A clinical overview. European Journal of Neurology, 38, 141–154.
   Google Scholar
• Önal, M. Z., & Fisher, M. (1996). Thrombolytic and cytoprotective therapies for acute ischemic stroke: A clinical overview. Drugs Today, 32, 573–592.
   Web of Science ®Google Scholar
• Önal, M. Z., Li, F., Tatlisumak, T., Locke, K. W., Sandage, B. W., & Fisher, M. (1997). Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats. Stroke, 28, 1060–1065.
   PubMed Web of Science ®Google Scholar
• Phillis, J. W., Song, D., & O’Regan, M. H. (1997). Inhibition by anion channel blockers of ischemia-evoked release of excitotoxic and other amino acids from rat cerebral cor- tex. Brain Research, 758, 9–16.
   PubMed Web of Science ®Google Scholar
• Rataud, J., Debemot, F., Mary, V., Pratt, S., & Stutzmann, J. M. (1994). Comparative study of voltage sensitive sodium channel blockers in focal ischemia and electric con- vulsions in rodents. Neuroscience Letters, 172, 19–23.
   PubMed Web of Science ®Google Scholar
• Scatton, B. (1994). Excitatory amino acid receptor antagonists. A novel treatment for is- chemic cerebrovascular diseases. Science, 55, 25–26.
   Google Scholar
• Schabitz, W. R., & Fisher, M. (2001). Pharmacologic neuroprotection for stroke. In M. Fisher (Ed.), Stroke therapy (pp. 275–285). Boston: Butterworth-Heinemann.
   Google Scholar
• Schabitz, W. R., Li, F., Irie, K., Sandage, B. W., Locke, K. W., & Fisher, M. (1999). Synergistic effects of a combination of low dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia. Stroke, 30, 427–432.
   PubMed Web of Science ®Google Scholar
• Schabitz, W. R., Weber, J., Takano, K., Sandage, B. W., Locke, K. W., & Fisher, M. (1996). The effects of prolonged treatment with citicoline in temporary experimental focal cerebral ischemia. Journal of Neurological Sciences, 138, 21–25.
   PubMed Web of Science ®Google Scholar
• Shuaib, A., Mahmood, R. H., Wishart, T., Kanthan, R., Murabit, M. A., & Ijaz, S., et al. (1995). Neuroprotective effects of lamotrigine in global ischemia in gerbils: A histo- logical, in vivo micro dialysis and behavioral study. Brain Research, 702, 199–206.
   PubMed Web of Science ®Google Scholar
• Smith, S. E., Lekieffre, D., Sowinski, P., & Meldrum, B. S. (1993). Cerebroprotective effect of BW619C89 after focal or global cerebral ischemia in the rat. Neuroreport, 4, 1339–1342.
   PubMed Web of Science ®Google Scholar
• Smith, S. E., & Meldrum, B. S. (1995). Cerebroprotective effect of lamotrigine after focal ischemia in rats. Stroke, 26, 117–122.
   PubMed Web of Science ®Google Scholar
• Spiers, P. A., Myers, D., Hochanadel, G. S., Lieberman, H. R., & Wurtman, R. J. (1996). Citicoline improves verbal memory in aging. Archives of Neurology, 53, 441–448.
   PubMed Web of Science ®Google Scholar
• Trovarelli, G., De Medio, G. E., Dorman, R. V., Piccinin, G. L., Horrocks, L. A., & Porcellatti, G. (1981). Effect of cytidine diphosphate choline (CDP-choline) on ischemia-induced alterations of brain lipid in the gerbil. Neurochemical Research, 6, 821–833.
   PubMed Web of Science ®Google Scholar
• Wang, S. J., Huang, C. C., Hsu, K. S., Tsai, J. J., & Gean, P. W. (1996). Presynaptic inhibition of excitatory neurotransmission by lamotrigine in the rat amygdalar neu- rons. Synapse, 24, 248–255.
   PubMed Web of Science ®Google Scholar
• Weiss, G. B. (1995). Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline. Life Science, 56, 637–660.
   PubMed Web of Science ®Google Scholar
• Wiard, R. P., Dickerson, M. C., Beek, O., Norton, R., & Cooper, B. R. (1995). Neuroprotective properties of the novel antiepileptic lamotrigine in a gerbil model of global cerebral ischemia. Stroke, 26, 466–472.
   PubMed Web of Science ®Google Scholar
• Yamamoto, M., Shimizu, M., & Okamiya, H. (1990). Pharmacological actions of a new TRH analogue, YM-14673, in rats subjected to cerebral ischemia and anoxia. Euro- pean Journal of Pharmacology, 181, 207–214.
   PubMed Web of Science ®Google Scholar
• Yatsu, F. M., & Moss, S. A. (1971). Brain lipid changes following hypoxia. Stroke, 2, 587–593.
   PubMed Web of Science ®Google Scholar
• Zea, L. E., Weinstein, P. R., Carlson, S., & Cummins, R. (1989). Reversible middle cere- bral artery occlusion without craniectomy in rats. Stroke, 20, 84–91.
   PubMed Web of Science ®Google Scholar
• Zivin, J. A. (1998). Current status of new drug development for ischemic stroke. In M. Fisher. (Ed.), Monographs in clinical neuroscience (pp 128–138). Basel: Karger.
   Google Scholar